Northern Trust EVP exercises $58.25 options, sells shares at ~$128
Rhea-AI Filing Summary
Northern Trust (NTRS): EVP and General Counsel Susan C. Levy reported insider transactions on 11/04/2025. She exercised an employee stock option for 27,591 shares at an exercise price of $58.25 and sold 20,414 shares at a weighted average price of $127.92, plus 7,177 shares at a weighted average price of $128.74.
Following these transactions, directly held common stock reported in the table moved through 75,848, 55,434, and then 48,257 shares as transactions posted. Indirect holdings include 38,026 shares in a 2024 GRAT and 35,412 shares in an irrevocable trust; the 2023 GRAT shows 0 shares following distributions noted in the footnotes.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: option exercise and matched sales.
The officer executed an option exercise for $58.25 per share covering 27,591 shares, then reported open market sales totaling the same number of shares at weighted average prices of $127.92 and $128.74. This sequence often reflects tax or portfolio management decisions but the filing lists only the transactions and prices.
Post-trade positions reflect direct holdings of 48,257 shares and indirect positions via a 2024 GRAT (38,026) and an irrevocable trust (35,412). The derivative table shows the reported option position reduced to 0. Overall, this is administrative in nature; market impact depends on context outside this excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right-to-buy) | 27,591 | $0.00 | -- |
| Exercise | Common Stock | 27,591 | $58.25 | $1.61M |
| Sale | Common Stock | 20,414 | $127.92 | $2.61M |
| Sale | Common Stock | 7,177 | $128.74 | $924K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 15,807 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock. Reflects the August 11, 2025 transfer of 12,795 shares directly held by the reporting person into the reporting person's existing irrevocable trust. On September 3, 2025, the reporting person's 2023 grantor retained annuity trust ("GRAT") distributed 14,750 shares of the Corporation's common stock to the reporting person's existing brokerage account as an annuity payment in accordance with the terms of the GRAT instrument. On September 3, 2025, the reporting person's 2024 GRAT distributed 17,700 shares of the Corporation's common stock to the reporting person's existing brokerage account as an annuity payment in accordance with the terms of the GRAT instrument. Price reflects the weighted average sales price from $127.49 to $128.49. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request. Price reflects the weighted average sales price from $128.50 to $129.24. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request. On September 4, 2025, the reporting person's 2023 GRAT distributed 10,480 shares of the Corporation's common stock to the reporting person's existing irrevocable trust as a final annuity payment in accordance with the terms of the GRAT instrument. The reporting person's spouse is trustee of this trust. This option became exercisable in four equal annual installments beginning 2/16/2017.
